
Wendy's rejects Peltz's $1.4B bid, adopts poison pill to defend turnaround plan
Wendy's board unanimously rejected a $1.4 billion all-cash takeover proposal from an investor group led by Nelson Peltz, deeming the offer undervalued. The company simultaneously activated a one-year 'poison pill' defense to deter hostile acquisitions. While the chain reported its seventh consecutive quarter of declining same-store sales, it exceeded Wall Street earnings expectations, with CEO Bob Wright citing a successful turnaround strategy.













